Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $176,658 - $227,517
-381 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $61,374 - $86,044
-117 Reduced 23.49%
381 $214,000
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $152,400 - $170,856
-215 Reduced 30.15%
498 $377,000
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $29,596 - $37,159
45 Added 6.74%
713 $533,000
Q2 2021

Aug 10, 2021

SELL
$576.64 - $649.04 $115,328 - $129,808
-200 Reduced 23.04%
668 $430,000
Q1 2021

May 10, 2021

BUY
$547.01 - $662.35 $32,273 - $39,078
59 Added 7.29%
868 $496,000
Q4 2020

Feb 11, 2021

SELL
$510.68 - $643.45 $7,149 - $9,008
-14 Reduced 1.7%
809 $472,000
Q2 2020

Aug 17, 2020

BUY
$334.87 - $493.06 $66,974 - $98,612
200 Added 32.1%
823 $372,000
Q4 2019

Feb 04, 2020

SELL
$319.73 - $374.2 $33,571 - $39,291
-105 Reduced 14.42%
623 $224,000
Q3 2019

Nov 07, 2019

BUY
$304.55 - $345.24 $221,712 - $251,334
728 New
728 $242,000
Q2 2018

Aug 14, 2018

SELL
$244.1 - $303.88 $213,343 - $265,591
-874 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$233.97 - $274.11 $204,489 - $239,572
874 New
874 $219,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.38B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.